Reduction in Non-Evidence-Based Proton-Pump Inhibitors Prescription on Discharge (Sustainability Phase)
Care Process & Redesign
Training ＆ Education
National Healthcare Group Quality Improvement
National Healthcare Group
31 December 2021
To reduce non-evidence-based PPI prescriptions in both inpatient and outpatient settings over a sustained period. Reducing unnecessary PPI prescriptions improves patient safety and healthcare efficiency.
Year Submitted: 2021
Published Date: 31 December 2021
Tags: Care Process ＆ Redesign, Training ＆ Education, Quality Improvement, Clinical Practice Improvement, Value Based Care, Safe Care, Adherence Rate, Learning Approach, Microlearning, Inter-Professional Education, Productivity, Cost Saving
About this Content
Aims
To reduce non-evidence-based PPI prescriptions in both inpatient and outpatient settings over a sustained period.
Background
PPI overutilization posed risks of adverse effects and increased healthcare costs.
Methods
Implemented a deprescribing guide, conducted roadshows, and carried out audits.
Results
Sustained a 43% reduction in non-evidence-based PPI prescriptions, saving $84,147 annually.
Conclusion
Reducing unnecessary PPI prescriptions improves patient safety and healthcare efficiency.
Lessons Learnt
Multidisciplinary collaboration and continual education are essential for sustaining deprescribing efforts.
Additional Information
NHG Quality Day 2021 Best Award
Keywords
Proton-Pump Inhibitors, Deprescribing, Cost Savings
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Tan Tock Seng Hospital |
Platform(s) | National Healthcare Group Quality Improvement |
Healthcare Professional Group(s) | Allied Health, Nursing, Medical, Pharmacy |
Applicable Specialty or Discipline | Pharmacology |
Project Lead(s) | Christina Tan Jiun Yu, Tan Yan Ru |
Project Member(s) | Lam Ming Ai |
Connect with this contributor!
Christina Tan Jiun Yu - christina_jy_tan@ttsh.com.sg